(CercleFinance.com) – On the occasion of the publication of its quarterly reports, Medtronic indicates that its board of directors has approved an increase in the dividend for the first quarter of the 2023-24 financial year, bringing its quarterly amount to 0, $69 per share.
In its fourth quarter of 2022-23, the medical equipment supplier saw its non-GAAP EPS increase by 3% to 1.57 dollars, for revenues of 8.5 billion dollars, an increase of 5 .6% in published data and organically.
For the year just starting, Medtronic anticipates non-GAAP EPS of between $5 and $5.10, as well as organic revenue growth of between 4 and 4.5%, compared to $5.29 and $2.1 respectively. % over the past year as a whole.
Copyright © 2023 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
